Shorts

Alexandra Drakaki, MD, on misdiagnosis of bladder cancer in women

Pearls & Perspectives: What is “normal” urination frequency?

Giulia Almiron da R. Soares on social media and urology recruitment

Jared S. Winoker, MD, on research comparing CVAC 2.0 vs FANS

James R. Porter, MD, discusses haptics and the Hugo RAS system

Matthias Saar, MD, outlines the rationale for the phase 2 INDUCTA trial in prostate cancer

Pearls & Perspectives: The trouble with voiding diaries

Is PCNL dead? with Ben H. Chew, MD, MSc, FRCSC

Alicia Morgans, MD, discusses cancer control with enzalutamide, apalutamide

Bogdana Schmidt, MD, MPH, on who could benefit most from ICI plus BCG in high-risk NMIBC

Neha Vapiwala, MD, explores the biggest prostate cancer takeaways from ASCO GU 2026

Christopher Pieczonka, MD, on what’s next for NAI plus BCG in BCG-naïve NMIBC

Sara Coca Membribes, MD, on what’s needed to refine the role of BCG-ICI combinations in NMIBC

Jean-Nicolas Cornu, MD, PhD, FEBU, on the patient population of VAPEUR-RCT in BPH

Antoni Vilaseca Cabo, MD, on the pharmacokinetics of erda-iDRS in NMIBC

Daniel J. George, MD, on the need for caregiver support in prostate cancer

Brian F. Chapin, MD, on adding local therapy to systemic treatment in metastatic prostate cancer

Declan Murphy, MB, BCH, on the implications of PRIMARY2 study for prostate cancer diagnosis

Andrea Necchi, MD, on the SURE-02 trial evaluating neoadjuvant sacituzumab govitecan plus pembrolizumab

Sam S. Chang, MD, MBA, on the significance of KEYNOTE-B15 data

James R. Porter, MD, on the modular architecture of the Hugo RAS

Maha Hussain, MD, on the significance of BRCAAway data in mCRPC

The Expert APProach: The importance of physician-directed care

Mathew D. Sorensen, MD, MS, FACS, on how Break Wave may reduce stent use

Robert S. Svatek, MD, MSCI, on the global evolution of BCG

Meri-Margaret Deoudes, CFRE, on bladder cancer diagnosis is often delayed in women

Pooja Ghatalia, MD, discusses ctDNA’s utility in MIBC

Stacy Loeb, MD, MSc, PhD (hon), on microplastics in prostate tumors

Melissa Moran, DO, on prescribing patterns for postmenopausal female HSDD

Ezra Margolin, MD, on antibiotic use in patients with stones